Furthermore, it has previously been reported that BLyS expression is directly linked to and regulated by interferon (IFN) signalling [20], and improved responses to IFN pathway inhibitors have been seen in patients with SLE and high IFN levels compared with low IFN in early SLE trials [21]. Here, IFNA1 is linked to systemic lupus erythematosus.